Latest Posts

Tag: Jennison Associates

Editas Medicine raised $120M for advance genome editing

Editas Medicine, a leading genome editing company, raised $120 million in a highly oversubscribed Series B private financing. It is noted that Editas is translating the promise of CRISPR/Cas9 technology into a new class of transformative genomic medicines to treat a broad range of diseases by enabling precise and corrective molecular modifications to treat disease […]

Keep Reading
Go to TOP